Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy

Yuto Hamada; Yuko Chinuki; Yuma Fukutomi; Eiji Nakatani; Akiko Yagami; Kayoko Matsunaga; Yoshiko Oda; Atsushi Fukunaga; Atsuko Adachi; Makiko Hiragun; Michihiro Hide; Eishin Morita

doi:10.1016/j.jaip.2019.10.008

Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy

Yuto Hamada, Yuko Chinuki, Yuma Fukutomi, Eiji Nakatani, Akiko Yagami, Kayoko Matsunaga, Yoshiko Oda, Atsushi Fukunaga, Atsuko Adachi, Makiko Hiragun, Michihiro Hide, Eishin Morita

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

9 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	1149-1151.e3
ジャーナル	Journal of Allergy and Clinical Immunology: In Practice
巻	8
号	3
DOI	https://doi.org/10.1016/j.jaip.2019.10.008
出版ステータス	出版済み - 03-2020

All Science Journal Classification (ASJC) codes

免疫アレルギー学

文献へのアクセス

10.1016/j.jaip.2019.10.008

他のファイルとリンク

引用スタイル

Hamada, Y., Chinuki, Y., Fukutomi, Y., Nakatani, E., Yagami, A., Matsunaga, K., Oda, Y., Fukunaga, A., Adachi, A., Hiragun, M., Hide, M., & Morita, E. (2020). Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy. Journal of Allergy and Clinical Immunology: In Practice, 8(3), 1149-1151.e3. https://doi.org/10.1016/j.jaip.2019.10.008

@article{5b5c951244184ae3b17907819f7f6e0d,

title = "Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy",

author = "Yuto Hamada and Yuko Chinuki and Yuma Fukutomi and Eiji Nakatani and Akiko Yagami and Kayoko Matsunaga and Yoshiko Oda and Atsushi Fukunaga and Atsuko Adachi and Makiko Hiragun and Michihiro Hide and Eishin Morita",

note = "Funding Information: This study was supported by a grant from the Japan Agency for Medical Research and Development (grant no. 17ek0410020h0003).Conflict of interests: Y. Chinuki, Y. Fukutomi, M. Hide, and E. Morita report grants from the Japan Agency for Medical Research and Development, during the conduct of the study. Y. Chinuki reports personal fees from Kaken, Kyouwa Hakko Kirin Co., Ltd, Kyorin Pharmaceutical Co., Ltd, Novartis Pharma K.K., MSD K.K., TAIHO Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Santen Pharmaceutical Co., Ltd, and Torii Pharmaceutical Co., Ltd, outside the submitted work. Y. Fukutomi reports personal fees from Thermo Fisher Diagnostics K.K., Torii Pharmaceutical Co., Ltd, Kyorin Pharmaceutical Co., Ltd, Novartis Pharma K.K., MSD K.K., and TAIHO Pharmaceutical Co., Ltd, outside the submitted work. E. Nakatani reports personal fees from Celgene K.K., outside the submitted work. A. Fukunaga reports personal fees from Kaken, Kyorin Pharmaceutical Co., Ltd, Sanofi K.K., TAIHO Pharmaceutical Co., Ltd, Shire Plc, Sumitomo Dainippon Phrma Co., Ltd, Torii Pharmaceutical Co., Ltd, Maruho Co., Ltd, and CSL Bering K.K.; grants and personal fees from Novartis Pharma K.K., and Mitsubishi Tanabe Pharma Corporation, outside the submitted work. M. Hide reports personal fees from Kaken, Kyorin Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Sysmex Corporation, and Teikoku Seiyaku Co., Ltd; grants and personal fees from Kyouwa Hakko Kirin Co., Ltd, Novartis Pharma K.K., MSD K.K., TAIHO Pharmaceutical Co. Ltd, SHIONOGI & Co., Ltd, Torii Pharmaceutical Co., Ltd, and Sanofi K.K., outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.",

year = "2020",

month = mar,

doi = "10.1016/j.jaip.2019.10.008",

language = "English",

volume = "8",

pages = "1149--1151.e3",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "3",

}

Hamada, Y, Chinuki, Y, Fukutomi, Y, Nakatani, E, Yagami, A , Matsunaga, K, Oda, Y, Fukunaga, A, Adachi, A, Hiragun, M, Hide, M & Morita, E 2020, 'Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy', Journal of Allergy and Clinical Immunology: In Practice, vol. 8, no. 3, pp. 1149-1151.e3. https://doi.org/10.1016/j.jaip.2019.10.008

TY - JOUR

T1 - Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy

AU - Hamada, Yuto

AU - Chinuki, Yuko

AU - Fukutomi, Yuma

AU - Nakatani, Eiji

AU - Yagami, Akiko

AU - Matsunaga, Kayoko

AU - Oda, Yoshiko

AU - Fukunaga, Atsushi

AU - Adachi, Atsuko

AU - Hiragun, Makiko

AU - Hide, Michihiro

AU - Morita, Eishin

N1 - Funding Information: This study was supported by a grant from the Japan Agency for Medical Research and Development (grant no. 17ek0410020h0003).Conflict of interests: Y. Chinuki, Y. Fukutomi, M. Hide, and E. Morita report grants from the Japan Agency for Medical Research and Development, during the conduct of the study. Y. Chinuki reports personal fees from Kaken, Kyouwa Hakko Kirin Co., Ltd, Kyorin Pharmaceutical Co., Ltd, Novartis Pharma K.K., MSD K.K., TAIHO Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Santen Pharmaceutical Co., Ltd, and Torii Pharmaceutical Co., Ltd, outside the submitted work. Y. Fukutomi reports personal fees from Thermo Fisher Diagnostics K.K., Torii Pharmaceutical Co., Ltd, Kyorin Pharmaceutical Co., Ltd, Novartis Pharma K.K., MSD K.K., and TAIHO Pharmaceutical Co., Ltd, outside the submitted work. E. Nakatani reports personal fees from Celgene K.K., outside the submitted work. A. Fukunaga reports personal fees from Kaken, Kyorin Pharmaceutical Co., Ltd, Sanofi K.K., TAIHO Pharmaceutical Co., Ltd, Shire Plc, Sumitomo Dainippon Phrma Co., Ltd, Torii Pharmaceutical Co., Ltd, Maruho Co., Ltd, and CSL Bering K.K.; grants and personal fees from Novartis Pharma K.K., and Mitsubishi Tanabe Pharma Corporation, outside the submitted work. M. Hide reports personal fees from Kaken, Kyorin Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Sysmex Corporation, and Teikoku Seiyaku Co., Ltd; grants and personal fees from Kyouwa Hakko Kirin Co., Ltd, Novartis Pharma K.K., MSD K.K., TAIHO Pharmaceutical Co. Ltd, SHIONOGI & Co., Ltd, Torii Pharmaceutical Co., Ltd, and Sanofi K.K., outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85075396161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075396161&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2019.10.008

DO - 10.1016/j.jaip.2019.10.008

M3 - Article

C2 - 31678299

AN - SCOPUS:85075396161

SN - 2213-2198

VL - 8

SP - 1149-1151.e3

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 3

ER -